EBV EA
(Epstein-Barr Virus Early Antigen (EBV EA))
Protein-Typ
Recombinant
Protein Region
AA 306-390
Spezies
Epstein-Barr Virus (EBV)
Quelle
Escherichia coli (E. coli)
Applikation
ELISA, Western Blotting (WB)
Produktmerkmale
Purified recombinant EBV EA protein Expression System: E.coli
Aufreinigung
Proprietary chromatographic technique
Reinheit
> 95 % pure
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
50 mM tris-HCl, pH 8.0, with 10 mM glutation, 60 mM NaCl and 0.5 % sarcosyl.
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
RT/-20 °C
Target
EBV EA
(Epstein-Barr Virus Early Antigen (EBV EA))
Substanzklasse
Viral Protein
Hintergrund
The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virusof the herpes family (which includes Herpes simplex virusand Cytomegalo virus. On infecting the B-lymphocyte, the linear virus genome circularizes and the virus subsequently persists within the cell as an episome. The virus can execute several distinct programs of gene expressionwhich can be broadly categorized as being lytic cycle or latent cycle. The lytic cycleor productive infection results in staged expression of a host of viral proteinswith the ultimate objective of producing infectious virions. Formally, this phase of infection does not inevitably lead to lysis of the host cellas EBV virions are produced by budding from the infected cell. The latent cycle(lysogenic) programs are those that do not result in production of virions. Alternative Names: EBV HHV4 EA protein, Epstein Barr, Epstein-Barr Virus Early Antigen protein